Jonathan Allan
GENERAL COUNSEL & CORP SEC · 7 filings · Latest: Oct 2, 2026
Stoke Therapeutics, Inc.
| Ticker | Owner | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total | SEC Filing |
|---|---|---|---|---|---|---|---|---|---|
STOK | Jonathan Allan | GENERAL COUNSEL & CORP SEC | Oct 2, 2026 | Sale | $26.33 | 627 | $16.5K | 20,598 | |
STOK | JONATHAN D ALLAN | — | Oct 2, 2026 | Proposed Sale | $26.01 | 627 | $16.3K | — | |
STOK | Jonathan Allan | GENERAL COUNSEL & CORP SEC | Aug 18, 2026 | Sale | $32.03 | 2,861 | $91.6K | 21,225 | |
STOK | Jonathan Allan | GENERAL COUNSEL & CORP SEC | Aug 14, 2026 | Option Exercise | $0.00 | 6,000 | — | 24,086 | |
STOK | Jonathan Allan | GENERAL COUNSEL & CORP SEC | Jun 16, 2026 | Sale | $29.95 | 1,457 | $43.6K | 18,086 | |
STOK | JONATHAN D ALLAN | — | Jun 16, 2026 | Proposed Sale | $30.00 | 1,457 | $43.7K | — | |
STOK | Jonathan Allan | GENERAL COUNSEL & CORP SEC | Mar 20, 2026 | Sale | $33.69 | 9,293 | $313.0K | 19,543 | |
STOK | JONATHAN ALLAN | — | Mar 20, 2026 | Proposed Sale | $33.19 | 9,293 | $308.4K | — | |
STOK | Jonathan Allan | GENERAL COUNSEL & CORP SEC | Mar 18, 2026 | Sale | $31.34 | 4,628 | $145.1K | 28,836 | |
STOK | Jonathan Allan | GENERAL COUNSEL & CORP SEC | Mar 17, 2026 | Sale | $33.01 | 4,267 | $140.8K | 33,464 | |
STOK | Jonathan Allan | GENERAL COUNSEL & CORP SEC | Mar 15, 2026 | Option Exercise | $0.00 | 25,475 | — | 37,731 | |
STOK | JONATHAN ALLAN | — | Dec 8, 2025 | Proposed Sale | $30.87 | 3,978 | $122.8K | — | |
STOK | JONATHAN ALLAN | — | Dec 5, 2025 | Proposed Sale | $31.05 | 7,781 | $241.6K | — | |
STOK | JONATHAN ALLAN | — | Oct 3, 2025 | Proposed Sale | $24.82 | 10,000 | $248.2K | — | |
STOK | JONATHAN ALLAN | — | Aug 29, 2025 | Proposed Sale | $19.77 | 22,117 | $437.3K | — | |
STOK | JONATHAN ALLAN | — | Aug 13, 2025 | Proposed Sale | $13.53 | 13,712 | $185.5K | — | |
STOK | JONATHAN ALLAN | — | Dec 9, 2024 | Proposed Sale | $13.27 | 12,114 | $160.8K | — |